29/06/2022

EuropaBio’s Vision for Europe: Innovation, Investment, Excellence

23/06/2022

DSM’s Patricia Malarkey appointed as new Chair of EuropaBio

20/06/2022

Seizing opportunities for continued innovation, investment, and excellence in orphan medicines in Europe

15/06/2022

EFIB 2022 Start-up Village: applications are open!

13/06/2022

EuropaBio’s Claire Skentelbery elected as new Vice-chair of ICBA

08/06/2022

EuropaBio participates at the BIO International Convention 2022 in San Diego

23/05/2022

Jamie Wilkinson new Healthcare Biotechnology Director at EuropaBio

16/05/2022

EuropaBio Statement on the Evaluation of the Cross-Border Healthcare Directive

12/05/2022

A New European Innovation Agenda: biotechnology will help achieve a healthier, more sustainable, and autonomous Europe

27/04/2022

EuropaBio SME BioForum: a new voice for the biotechnology SME community in Europe

24/04/2022

EuropaBio published policy recommendations for the healthcare and industrial biotechnology sectors

11/04/2022

Registration is now open for #EFIB2022: benefit from the early bird fee

05/04/2022

Become a partner of European Biotech Week 2022

04/04/2022

EuropaBio NAC Summit 2022: key recommendations on how National associations can deliver Europe’s innovation, investment and excellence in biotechnology

11/03/2022

EuropaBio Statement on the Russian Invasion of Ukraine

08/03/2022

EuropaBio National Associations Council Summit 2022: modernised regulation and legislation will deliver the potential of European biotechnology

17/02/2022

EuropaBio signs EU Code of Conduct

01/02/2022

EuropaBio National Associations Council Summit 2022 (French Presidency): how does biotechnology deliver the Industrial strategy across sectors?

31/01/2022

EuropaBio becomes a partner of a new European partnership for health

02/08/2021

EuropaBio response to the European Commission Public Consultation on the Regulations for Orphan Medicinal Products and Paediatrics

EuropaBio has responded to the European Commission’s public consultation on the Orphan Medicinal Products (OMPs) and Paediatrics Regulations.
Become a member